Your browser doesn't support javascript.
loading
A single, improbable B cell receptor mutation confers potent neutralization against cytomegalovirus.
Jenks, Jennifer A; Amin, Sharmi; Sponholtz, Madeline R; Kumar, Amit; Wrapp, Daniel; Venkatayogi, Sravani; Tu, Joshua J; Karthigeyan, Krithika; Valencia, Sarah M; Connors, Megan; Harnois, Melissa J; Hora, Bhavna; Rochat, Eric; McLellan, Jason S; Wiehe, Kevin; Permar, Sallie R.
Affiliation
  • Jenks JA; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
  • Amin S; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
  • Sponholtz MR; Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas, United States of America.
  • Kumar A; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
  • Wrapp D; Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas, United States of America.
  • Venkatayogi S; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
  • Tu JJ; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
  • Karthigeyan K; Department of Pediatrics, Weill Cornell Medicine, New York, New York, United States of America.
  • Valencia SM; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
  • Connors M; Department of Pediatrics, Weill Cornell Medicine, New York, New York, United States of America.
  • Harnois MJ; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
  • Hora B; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
  • Rochat E; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
  • McLellan JS; Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas, United States of America.
  • Wiehe K; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
  • Permar SR; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America.
PLoS Pathog ; 19(1): e1011107, 2023 01.
Article in En | MEDLINE | ID: mdl-36662906
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cytomegalovirus Infections / Cytomegalovirus Vaccines / Cytomegalovirus / Antibodies, Neutralizing / Antibodies, Viral Limits: Humans Language: En Journal: PLoS Pathog Year: 2023 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cytomegalovirus Infections / Cytomegalovirus Vaccines / Cytomegalovirus / Antibodies, Neutralizing / Antibodies, Viral Limits: Humans Language: En Journal: PLoS Pathog Year: 2023 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos